Matthew Romo

Matthew Romo, PharmD, PhD, MPH, is a Research Fellow in Global Health and Social Medicine at Harvard Medical School, working with Dr. Molly Franke on drug-resistant tuberculosis research. He holds expertise in epidemiology and pharmacy, with prior experience at the US Military HIV Research Program focusing on global HIV prevention, treatment, and cure. His work spans infectious diseases, particularly HIV, neurocysticercosis, and tuberculosis, with a focus on global health equity and marginalized populations.

Romo's research interests include the epidemiology of infectious diseases, healthcare access in low-resource settings, and the intersection of public health interventions with vulnerable groups such as truck drivers and people living with HIV. His studies frequently address implementation gaps in preventive measures (e.g., PrEP) and treatment adherence, particularly in Sub-Saharan Africa and Latin America.

His articles highlight themes like HIV post-exposure prophylaxis uptake, asymptomatic SARS-CoV-2 infections among HIV patients, and disparities in antiretroviral therapy access. He has contributed to understanding neurocysticercosis pathophysiology and treatment outcomes, as well as the impact of dolutegravir on weight gain and adherence.

Romo's work emphasizes global health challenges, including pandemic responses (e.g., vaccine safety in military populations) and chronic disease comorbidities in HIV-positive individuals. His interdisciplinary approach combines epidemiological analysis with clinical and behavioral insights to address systemic healthcare inequities.